32 results
ARS
2023 FY
CRBU
Caribou Biosciences Inc
25 Apr 24
Annual report to shareholders
4:06pm
; reputational harm; diminished profits; and the curtailment or restructuring of our operations. If any of the physicians or other providers or Table of Contents … , industrial espionage attacks, or insider threat attacks, which could result in financial, legal, business, or reputational harm. Our employees, clinical
ARS
8w76d 2rql
28 Apr 23
Annual report to shareholders
12:00am
DEF 14A
j3qkd cmbzhyex28p
11 Aug 22
Definitive proxy
4:04pm
10-K
EX-10.42
yr8538o50m554asy
21 Mar 22
Annual report
4:19pm
10-K
kbpilt
21 Mar 22
Annual report
4:19pm
10-K
EX-10.39
cqrsk
21 Mar 22
Annual report
4:19pm
8-K
EX-10.3
05p3j7ay8k
28 Jul 21
Unregistered Sales of Equity Securities
4:05pm
8-K
EX-10.4
jvnpl 3y6mnq
28 Jul 21
Unregistered Sales of Equity Securities
4:05pm
8-K
EX-10.2
wn3dn rwp3v
28 Jul 21
Unregistered Sales of Equity Securities
4:05pm
8-K
EX-10.1
j96yh
28 Jul 21
Unregistered Sales of Equity Securities
4:05pm
424B4
6bwutzyxq vdjpsxohi
23 Jul 21
Prospectus supplement with pricing info
4:24pm
S-1/A
EX-10.38
ugjce1dm
19 Jul 21
IPO registration (amended)
6:09am
S-1/A
EX-10.40
1k2ixk4ov
19 Jul 21
IPO registration (amended)
6:09am
S-1/A
eiz0j60t g4olekjmg
19 Jul 21
IPO registration (amended)
6:09am
S-1/A
EX-10.34
uoncmvx2qoieuztzo2yf
19 Jul 21
IPO registration (amended)
6:09am